Asia Pacific Non-Invasive Prenatal Testing Market By Instruments (Ultrasound, NGS, PCR, Microarray), Method (FCMB, Cf-DNA), By Application (Trisomy, Microdeletion, Genetics, Rh Factor), By End User (Hospital, Diagnostic Labs) And By Region – Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023
Asia Pacific Non-Invasive Prenatal Testing Market By Instruments (Ultrasound, NGS, PCR, Microarray), Method (FCMB, Cf-DNA), By Application (Trisomy, Microdeletion, Genetics, Rh Factor), By End User (Hospital, Diagnostic Labs) And By Region – Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023
ID: 2821 | Pages: 140 | October 2018 | Region: Asia Pacific
The Asia Pacific Non-Invasive Prenatal Testing Market was worth USD 0.39 Billion in 2018 and is projected to be growing at a CAGR of 20.3%, to touch USD 0.98 billion by 2023. During pregnancy, fetal DNA is freely circulating through the mother’s blood and is known as cell free DNA (cf-DNA). The analysis of this cf-DNA is one of the methods of Non-Invasive Prenatal Testing.
Non-Invasive Prenatal Testing, also known as Non-Invasive Prenatal Screening is the latest development in genetic testing which screens a mother’s blood during pregnancy and accurately identifies the most common genetic disorders such as the Down Syndrome, Patau Syndrome and Edward Syndrome. Among its other uses, is the gender determination of a baby.
The growth of the Asia-Pacific Non-Invasive Prenatal Testing Market is mainly driven by factors such as high prevalence of genetic disorders distributed in a huge population base, growing awareness about genetic abnormalities, leaps in technological advancements and the customer preference for non-invasive techniques over invasive ones. Low clinical validity of Non-Invasive Prenatal Testing results is one of the major constraints of the market.
The Asia-Pacific Non-Invasive Prenatal Testing Market is segmented based on Instruments, Method of Screening, Application, End User and geography. Based on Instruments, the market is divided into Ultrasound, NGS, PCR and Microarray. Based on Method, the Non-Invasive Prenatal Testing Market is segmented into FCMB and cf-DNA. Further, by Application, the market is branched into Trisomy, Microdeletion, Genetics, and Rh factor. Based on the End User, it is categorized into Hospital and Diagnostic Labs.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Factors such as growing demographics with rising awareness and growing disposable incomes due to emerging economies in countries such as India and China are expected to lead the growth of the market in this region. In fact, Asia-Pacific is the fast developing NIPT market which is reflected in its CAGR of more than 20%, which is the highest globally. Availability of humongous untapped markets and huge population base are driving the upsurge in growth.
The Asia-Pacific Non-Invasive Prenatal Testing market is very much disjointed in nature with the existence of international and local players. The significant players in the Asia-Pacific Non-Invasive Prenatal Testing market are GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), and Beijing Genomics Institute (China)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Instruments
5.1.1 Introduction
5.1.2 PCR
5.1.3 Ultrasound
5.1.4 NGS
5.1.5 Microarray
5.1.6 Y-o-Y Growth Analysis, By Instruments
5.1.7 Market Attractiveness Analysis, By Instruments
5.1.8 Market Share Analysis, By Instruments
5.2 Method
5.2.1 Introduction
5.2.2 FCMB
5.2.3 Cell-Free DNA (cf-DNA)
5.2.4 Y-o-Y Growth Analysis, By Method
5.2.5 Market Attractiveness Analysis, By Method
5.2.6 Market Share Analysis, By Method
5.3 Application
5.3.1 Introduction
5.3.2 Trisomy
5.3.3 Microdeletion
5.3.4 Genetics
5.3.5 Rh factor
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospital
5.4.3 Diagnostic Labs
5.4.4 Y-o-Y Growth Analysis, By End User
5.4.5 Market Attractiveness Analysis, By End User
5.4.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Instruments
6.1.3.3 By Method
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Instruments
6.1.4.3 By Method
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Instruments
6.1.5.3 By Method
6.1.5.4 By Application
6.1.5.5 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Koninklijke Philips N.V
8.3 Thermo Fisher Scientific
8.4 Hoffman-La Roche
8.5 Pacific Biosciences of California
8.6 PerkinElmer
8.7 QIAGEN N.V
8.8 Agilent Technologies
8.9 Beijing Genomics Institute
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Asia-Pacific Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- Asia-Pacific Ultrasound Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific NGS Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific PCR Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Microarray Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- Asia-Pacific FCMB Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific cf-DNA Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- Asia-Pacific Trisomy Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Microdeletion Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Genetics Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Rh Factor Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
- Asia-Pacific Hospital Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Diagnostic Labs Market By Region, From 2018-2023 ( USD Billion )
- Japan Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- Japan Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- Japan Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- Japan Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
- China Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- China Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- China Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- China Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
- India Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- India Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- India Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- India Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
- Australia Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- Australia Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- Australia Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- Australia Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
- South Korea Non-Invasive Prenatal Testing Market By Instruments, From 2018-2023 ( USD Billion )
- South Korea Non-Invasive Prenatal Testing Market By Method, From 2018-2023 ( USD Billion )
- South Korea Non-Invasive Prenatal Testing Market By Application, From 2018-2023 ( USD Billion )
- South Korea Non-Invasive Prenatal Testing Market By End User, From 2018-2023 ( USD Billion )
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance